{"blog": [], "keywords": [{"value": "Shkreli, Martin (1983- )", "name": "persons", "rank": "1", "is_major": "Y"}, {"value": "Securities and Commodities Violations", "name": "subject", "rank": "2", "is_major": "Y"}, {"value": "Drugs (Pharmaceuticals)", "name": "subject", "rank": "3", "is_major": "Y"}, {"value": "KaloBios Pharmaceuticals Inc.", "name": "organizations", "rank": "4", "is_major": "N"}, {"value": "Retrophin Inc", "name": "organizations", "rank": "5", "is_major": "N"}, {"value": "Turing Pharmaceuticals AG", "name": "organizations", "rank": "6", "is_major": "Y"}, {"value": "Brafman, Benjamin", "name": "persons", "rank": "7", "is_major": "N"}], "web_url": "http://www.nytimes.com/2016/02/04/business/martin-shkreli-appears-to-adopt-a-new-legal-strategy-silence.html", "document_type": "article", "byline": {"person": [{"lastname": "GOLDSTEIN", "firstname": "Matthew", "role": "reported", "organization": "", "rank": 1}, {"lastname": "STEVENSON", "firstname": "Alexandra", "role": "reported", "organization": "", "rank": 2}], "original": "By MATTHEW GOLDSTEIN and ALEXANDRA STEVENSON"}, "type_of_material": "News", "multimedia": [{"url": "images/2016/02/04/business/04shkreli-web2/04shkreli-web2-thumbWide.jpg", "legacy": {"wide": "images/2016/02/04/business/04shkreli-web2/04shkreli-web2-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "subtype": "wide", "type": "image", "width": 190, "height": 126}, {"url": "images/2016/02/04/business/04shkreli-web2/04shkreli-web2-articleLarge.jpg", "legacy": {"xlarge": "images/2016/02/04/business/04shkreli-web2/04shkreli-web2-articleLarge.jpg", "xlargeheight": "440", "xlargewidth": "600"}, "subtype": "xlarge", "type": "image", "width": 600, "height": 440}, {"url": "images/2016/02/04/business/04shkreli-web2/04shkreli-web2-thumbStandard.jpg", "legacy": {"thumbnail": "images/2016/02/04/business/04shkreli-web2/04shkreli-web2-thumbStandard.jpg", "thumbnailheight": "75", "thumbnailwidth": "75"}, "subtype": "thumbnail", "type": "image", "width": 75, "height": 75}], "section_name": "Business Day", "word_count": "683", "source": "The New York Times", "subsection_name": null, "lead_paragraph": "Mr. Shkreli\u2019s new defense lawyer, Benjamin Brafman, said he had advised his client, who faces securities fraud charges, to stop talking to the media and posting on Twitter.", "pub_date": "2016-02-04T00:00:00Z", "news_desk": "Business", "headline": {"print_headline": "Accepting Lower Profile, Shkreli Appears in Court", "main": "Martin Shkreli Appears to Adopt a New Legal Strategy: Silence"}, "print_page": "3", "snippet": "Mr. Shkreli\u2019s new defense lawyer, Benjamin Brafman, said he had advised his client, who faces securities fraud charges, to stop talking to the media and posting on Twitter.", "_id": "56b26d2b38f0d82036f0a842", "slideshow_credits": null, "abstract": "Martin Shkreli, according to his defense lawyer Benjamin Brafman, has been advised to keep low profile in court, on social media and with news media; Brafman says his client will assert his Fifth Amendment rights during scheduled testimony before House Committee on Oversight and Government Reform."}